Otsuka Pharmaceutical Development and Commercialization, Inc., United States
Disclosure information not submitted.
SP04D - Challenges and Recommendations in Understanding National Guidance and Marketing Authorization Holder Experiences for Implementing Additional Risk Minimization Measures in the European Union and the United Kingdom
Tuesday, August 24, 20213:30 PM – 4:45 PM US Eastern Time